journal article·2024-03-14Open access

It may all come down to the mechanisms of nanoparticle delivery

Authors not provided

Nature Reviews Bioengineering· Volume 2· Issue 3

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (6)

Show source-provided references
1. Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387–6392 (1986).
2. Park, K. The drug delivery field at the inflection point: Time to fight its way out of the egg. J. Control. Release. 267, 2–14 (2017).10.1016/j.jconrel.2017.07.030 ↗
3. The two directions of cancer nanomedicine. Nat. Nanotechnol. 14, 1083 (2019).10.1038/s41565-019-0597-5 ↗
4. van der Meel, R. et al. Smart cancer nanomedicine. Nat. Nanotechnol. 14, 1007–1017 (2019).10.1038/s41565-019-0567-y ↗
5. Nguyen, L. N. M. et al. The exit of nanoparticles from solid tumours. Nat. Mater. 22, 1261–1272 (2023).10.1038/s41563-023-01630-0 ↗
6. Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566–575 (2020).10.1038/s41563-019-0566-2 ↗